Tammy Boyce | Executive Director, Clinical Operations
Dynavax Technologies

Tammy Boyce is Executive Director, Clinical Operations at Dynavax where she and her team are responsible for translating the company’s clinical development strategies into effective clinical trials in support of its mission to help protect the world against infectious disease.  She is responsible for the execution of the company’s ongoing vaccine studies in Pertussis-Tdap, Shingles, and Plague.  Tammy has over 30 years of global drug development experience in conducting Phase I-IV clinical trials, and expanded access and compassionate use programs.